Delivery Order SPE2DR25D2005-SPE2DR26FE8S0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,061.48 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing indefinite delivery contract vehicle with DLA. The ultimate completion date is November 10, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $45,704.26 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed-price delivery order with no set-aside designation, issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,714.99 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of October 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $4,100.06. This is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,018.56 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of December 12, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product fulfillment under the Defense Logistics Agency's medical supply procurement operations. The award was made to AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,915.36 on December 2, 2025, for the supply of Lupron Depot 22.5 mg 3-month kits, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lupron Depot 22.5 mg three-month kits valued at $3,975.73. This is a firm fixed-price, non-set-aside delivery order with a completion date of November 28, 2025, and performance is based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,661.96 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was awarded on September 22, 2025 with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a $10,511.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of July 18, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8S0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,928.46 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a single delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as the overarching vehicle for this pharmaceutical supply. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Lupron Depot delivery supports the Defense Health Agency and other government healthcare systems' medical supply requirements. This delivery order exemplifies the company's role in fulfilling specialized pharmaceutical needs through DLA's global pharmaceutical support operations for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/10/25 |